MX9802817A - Un agente para curar padecimientos oftalmologicos. - Google Patents

Un agente para curar padecimientos oftalmologicos.

Info

Publication number
MX9802817A
MX9802817A MX9802817A MX9802817A MX9802817A MX 9802817 A MX9802817 A MX 9802817A MX 9802817 A MX9802817 A MX 9802817A MX 9802817 A MX9802817 A MX 9802817A MX 9802817 A MX9802817 A MX 9802817A
Authority
MX
Mexico
Prior art keywords
curing
carbostyril derivative
ophthalmological diseases
curing ophthalmological
agent
Prior art date
Application number
MX9802817A
Other languages
English (en)
Inventor
Hiroki Urashima
Yasuhiro Takeji
Hisashi Shinohara
Shigeki Fujisawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MX9802817A publication Critical patent/MX9802817A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invencion proporciona un agente para curar padecimientos oftalmologicos los cuales contienen, como el ingrediente activo, un derivado carboestirilo o una sal del mismo representada por la formula general (I) (en donde R es unátomo de halogeno) particularmente la invencion proporciona un agente efectivo para curar el síndrome de xeroftalmina (ojo seco).
MX9802817A 1995-10-12 1998-04-08 Un agente para curar padecimientos oftalmologicos. MX9802817A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26389695 1995-10-12
JP5733796 1996-03-14

Publications (1)

Publication Number Publication Date
MX9802817A true MX9802817A (es) 1998-09-30

Family

ID=26398366

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9802817A MX9802817A (es) 1995-10-12 1998-04-08 Un agente para curar padecimientos oftalmologicos.

Country Status (16)

Country Link
US (1) US6060486A (es)
EP (1) EP0859615B1 (es)
KR (1) KR100281865B1 (es)
CN (1) CN1132580C (es)
AR (3) AR004214A1 (es)
AT (1) ATE201992T1 (es)
AU (1) AU709734B2 (es)
CA (1) CA2234247C (es)
DE (1) DE69613386T2 (es)
DK (1) DK0859615T3 (es)
ES (1) ES2159043T3 (es)
GR (1) GR3036457T3 (es)
MX (1) MX9802817A (es)
PT (1) PT859615E (es)
TW (1) TW446702B (es)
WO (1) WO1997013515A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506412B2 (en) 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
DE10133870A1 (de) * 2001-07-12 2003-02-06 Chris P Lohmann Ophthalmisches Mittel, Verwendung von EGF zur Behandlung von Dry Eye-Syndrom und Insert zur Verabreichung von EGF am Auge
KR100907407B1 (ko) * 2002-09-28 2009-07-10 주식회사 케이티 대량 메시지 동보 전송을 위한 메시지 예약 및 전송 방법
DE602004009079T2 (de) * 2003-07-30 2008-06-19 Otsuka Pharmaceutical Co., Ltd. Carbostyril-derivative zur beschleunigten speichelabsonderung
EP1683526B1 (en) * 2003-11-14 2012-04-11 Senju Pharmaceutical Co., Ltd. Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
KR20070061537A (ko) 2004-08-27 2007-06-13 센주 세이야꾸 가부시키가이샤 건성안 치료용 안약액
TWI363626B (en) 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
TWI415629B (zh) * 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法
CA2725487A1 (en) * 2008-06-19 2009-12-23 Otsuka Pharmaceutical Co., Ltd. A pharmaceutical composition
CN103476753B (zh) 2011-02-25 2015-12-09 诺弗米克斯有限公司 新的瑞巴派特复合物和共晶体
TW201322982A (zh) 2011-11-01 2013-06-16 Otsuka Pharma Co Ltd 用於治療前眼疾病之藥劑，該藥劑包含瑞巴派特及眼淚保持劑
KR101692578B1 (ko) * 2013-04-18 2017-01-03 삼진제약주식회사 레바미피드 또는 이의 전구체를 포함하는 안구건조증의 예방 또는 치료를 위한 경구용 약제학적 조성물
WO2015168629A1 (en) 2014-05-02 2015-11-05 Massachusetts Eye And Ear Infirmary Grading corneal fluorescein staining
KR102307958B1 (ko) 2015-10-01 2021-10-05 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
KR20170039347A (ko) 2015-10-01 2017-04-11 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
WO2018163151A1 (en) 2017-03-05 2018-09-13 Resdevco Research And Development Co. Ltd. Eye drops for treatment of irritation not due to infection
KR102615076B1 (ko) 2021-07-14 2023-12-19 대우제약 주식회사 안정한 레바미피드 점안제의 대용량 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI80022C (fi) * 1982-07-05 1990-04-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart karbostyrilderivat.
JPH0713138B2 (ja) * 1986-07-30 1995-02-15 保土谷化学工業株式会社 ポリテトラメチレンエ−テルグリコ−ルの製法
DE69207560T2 (de) * 1991-06-07 1996-06-27 Otsuka Pharma Co Ltd Antidiabetikum
TW227558B (es) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
TW290541B (es) * 1993-03-18 1996-11-11 Otsuka Pharma Factory Inc
ES2138092T3 (es) * 1993-10-21 2000-01-01 Otsuka Pharma Co Ltd Utilizacion de los derivados de carbostirilo para la obtencion de un medicamento destinado para inhibir la produccion de la interleucina-8.
MX9701010A (es) * 1994-08-10 1997-05-31 Otsuka Pharma Co Ltd Un preventivo y un remedio para herida y/o inflamacion oftalmica.

Also Published As

Publication number Publication date
ES2159043T3 (es) 2001-09-16
CN1132580C (zh) 2003-12-31
AU709734B2 (en) 1999-09-02
PT859615E (pt) 2001-09-28
AR004214A1 (es) 1998-11-04
GR3036457T3 (en) 2001-11-30
TW446702B (en) 2001-07-21
CN1202108A (zh) 1998-12-16
DE69613386T2 (de) 2002-05-23
US6060486A (en) 2000-05-09
AR055393A2 (es) 2007-08-22
DK0859615T3 (da) 2001-09-03
EP0859615A1 (en) 1998-08-26
CA2234247C (en) 2005-05-10
ATE201992T1 (de) 2001-06-15
EP0859615B1 (en) 2001-06-13
WO1997013515A1 (en) 1997-04-17
CA2234247A1 (en) 1997-04-17
AU7097596A (en) 1997-04-30
KR100281865B1 (ko) 2001-02-15
DE69613386D1 (de) 2001-07-19
KR19990064187A (ko) 1999-07-26
AR070051A2 (es) 2010-03-10

Similar Documents

Publication Publication Date Title
MX9802817A (es) Un agente para curar padecimientos oftalmologicos.
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
AU1399492A (en) Remedies for bone diseases
NO950297D0 (no) Prolinamidderivater
WO2002081448A1 (fr) Derive benzamidine
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
GR3025568T3 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia.
NO982873D0 (no) 1-metylkarbapenemderivater
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
BRPI0317188A2 (pt) Novo derivado de 2,4-diamino-1,3,5-triazina
FI952420A0 (fi) Glukopyranosidibentsotiofeenit
AU6309398A (en) Agent for preventing and/or treating cachexia
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
SE9704770D0 (sv) New use
MXPA03011790A (es) Agente para la procteccion de neuronas de la retina.
NO993911D0 (no) Remedier/Forebygningsmidler for åndedrettssykdommer
MX9701010A (es) Un preventivo y un remedio para herida y/o inflamacion oftalmica.
AU7962000A (en) Us0027324for eating disorders
TW362097B (en) 3-Phenyl-1, 4-dialkyl-1,2,4-triazolium salts and their use as antidepressants